Carole J. Spangler
Corporate Officer/Principal chez Clario Medical Imaging, Inc.
Profil
Carole Spangler is Head of Sales for Clario Medical Imaging, Inc. Previously, she was Director of Business Development for Dendreon Corp.
She is an Adjunct Professor at the School of Business and Economics at Seattle Pacific University.
Dr. Spangler received an MBA from the University of Washington and a PhD from the Johns Hopkins University.
Postes actifs de Carole J. Spangler
| Sociétés | Poste | Début |
|---|---|---|
Clario Medical Imaging, Inc.
 Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Anciens postes connus de Carole J. Spangler
| Sociétés | Poste | Fin |
|---|---|---|
| DENDREON CORPORATION | Corporate Officer/Principal | - |
Formation de Carole J. Spangler
| The Johns Hopkins University | Doctorate Degree |
| University of Washington | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Clario Medical Imaging, Inc.
Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
